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Histone Deacetylase 4 Controls Chondrocyte
Hypertrophy during Skeletogenesis
anced by histone deacetylation, which favors chromatin
condensation and transcriptional repression.
There are two major classes of histone deacetylases
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consist mainly of a catalytic domain. In contrast, the1Department of Molecular Biology
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restricted patterns of expression and contain an N-ter-3 Department of Internal Medicine
minal extension that links them to specific transcriptionUniversity of Texas Southwestern Medical Center
factors and confers responsiveness to a variety of signal6000 Harry Hines Boulevard
transduction pathways, thereby connecting the genomeDallas, Texas 75390
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While the consequences of histone acetylation andHistone deacetylases (HDACs) modulate cell growth
deacetylation have been analyzed extensively in cul-and differentiation by governing chromatin structure
tured cells and cell-free systems, relatively little is knownand repressing the activity of specific transcription
of the specific functions of HDACs in vivo. HDAC5 andfactors. We showed previously that HDAC9 acts as a
9 are the only class II HDACs to have been inactivatednegative regulator of cardiomyocyte hypertrophy and
in the mouse. Mice lacking HDAC9 are viable, but theirskeletal muscle differentiation. Here we report that
hearts respond to stress by profound hypertrophicHDAC4, which is expressed in prehypertrophic chon-
growth (Zhang et al., 2002; Chang et al., 2004), sug-drocytes, regulates chondrocyte hypertrophy and en-
gesting that HDAC5 and 9 act as a transcriptional repres-dochondral bone formation by interacting with and
sor of cardiac hypertrophy. Consistent with this notion,inhibiting the activity of Runx2, a transcription factor
HDAC9 interacts with and suppresses the activity ofnecessary for chondrocyte hypertrophy. HDAC4-null
the MEF2 transcription factor (Zhang et al., 2001), anmice display premature ossification of developing
activator of hypertrophic gene expression. The role ofbones due to ectopic and early onset chondrocyte
HDAC9 (and other class II HDACs) as antagonists ofhypertrophy, mimicking the phenotype that results
cardiac hypertrophy is further supported by the findingsfrom constitutive Runx2 expression in chondrocytes.
that hypertrophic signals lead to the phosphorylation ofConversely, overexpression of HDAC4 in proliferating
these HDACs and their nuclear export, and mutantchondrocytes in vivo inhibits chondrocyte hypertrophy
HDAC proteins that are signal resistant prevent cardio-and differentiation, mimicking a Runx2 loss-of-func-
myocyte hypertrophy (Zhang et al., 2002).tion phenotype. These results establish HDAC4 as a
During embryonic development, the majority of bonescentral regulator of chondrocyte hypertrophy and
form through a process of endochondral ossification
skeletogenesis and suggest general roles for class II
in which mesenchymal cells first form a cartilaginous
HDACs in the control of cellular hypertrophy. template of the future bone (Karsenty and Wagner,
2002). Chondrocytes in the center of these elements
Introduction undergo hypertrophy and secrete an extracellular matrix
that becomes mineralized and allows vascular invasion
Regulated changes in chromatin structure play a central to occur. Thereafter, osteoblasts produce an extracellu-
role in the control of gene transcription. Posttransla- lar matrix rich in type I collagen that replaces the cartilag-
tional modifications of nucleosomal histones have been inous template. Chondrocyte hypertrophy is essential
proposed to influence chromatin structure and to create for vascular invasion, osteoblast differentiation, and en-
a code that is interpreted by positive and negative tran- dochondral ossification (Kronenberg, 2003; Olsen et al.,
scriptional regulators that recognize specific histone 2000). To date, the only transcription factor shown to
modifications. Histone acetylation, catalyzed by histone be required for chondrocyte hypertrophy is runt-related
acetyltransferases (HATs), promotes gene transcription transcription factor-2 (Runx2), which is also necessary
by relaxing chromatin structure, thereby facilitating ac- for osteoblast differentiation (Karsenty and Wagner,
cess of the transcriptional machinery to DNA target 2002).
sequences (Jenuwein and Allis, 2001). The transcription- In the present study, we generated mice lacking
activating effect of histone acetylation is counterbal- HDAC4; the mice display a remarkable phenotype char-
acterized by inappropriate chondrocyte hypertrophy
leading to ectopic bone formation, abnormalities analo-*Correspondence: eric.olson@utsouthwestern.edu
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Figure 1. Generation of HDAC4-Null Mice
(A) Schematic representation of the HDAC4 gene, the targeting vector, and the targeted gene. The first nine exons of the HDAC4 gene are
shown with the 5 and 3 genomic regions used for homologous recombination. A nuclear-localized lacZ expression cassette was inserted
in-frame into exon 6.
(B) Representative Southern blot of genomic DNA from wild-type and HDAC4 heterozygous and homozygous null animals digested with
BamHI. The position of the probe is shown in (A).
(C) Photograph of postnatal day 8 (P8) wild-type and HDAC4-null pups.
(D) Genotypes of 10-day-old pups from matings of HDAC4/ mice.
(E) RNA from hearts and brains of mice of the indicated genotypes was analyzed by RT-PCR for transcripts of the indicated HDACs. Transcripts
for HPRT were detected as a control for RNA loading and integrity.
gous to the phenotype observed in mice with constitu- chromosome 1. The targeting strategy is depicted in
tive expression of Runx2 in chondrocytes (Takeda et al., Figure 1A in the context of the first nine exons of the
2001; Ueta et al., 2001). We demonstrate that HDAC4, HDAC4 locus. The targeting vector was designed to
which is expressed in prehypertrophic chondrocytes, insert a nuclear-localized lacZ cassette into exon 6 such
associates with and inhibits the activity of Runx2. Fur- that lacZ was in-frame with amino acid 162 of HDAC4.
thermore, ectopic overexpression of HDAC4 in prolifer- This mutation resulted in deletion of the MEF2 binding
ating chondrocytes in vivo inhibits hypertrophy and, domain of HDAC4, as well as the nuclear localization
thus, ossification of the developing bone, mimicking the sequence and the complete deacetylase catalytic do-
Runx2 loss-of-function phenotype (Inada et al., 1999; main. Homologous recombination was confirmed by
Komori et al., 1997). These results establish HDAC4 as Southern blot analysis of ES cells (Figure 1B), which
a key regulator of chondrocyte hypertrophy and thereby were used to generate HDAC4 mutant mice.
skeletal development and suggest a general role for Intercrosses of HDAC4/ mice in either the isogenic
class II HDACs as negative regulators of cellular hyper- 129Sv/EV background or in a 129Sv/EV-C57BL/6 mixed
trophy during development and disease. genetic background yielded HDAC4-null offspring at
Mendelian ratios at birth (data not shown). Within the
first few days after birth, homozygous mutants wereResults
readily identifiable by their “dome-shaped” heads and
misshaped spines (Figure 1C). A subset of HDAC4 mu-Generation of HDAC4/ Mice
tants also displayed exencephaly (data not shown). ByTo investigate the function of HDAC4 in vivo, we dis-
postnatal day (P) 10, HDAC4-null mice were severelyrupted the mouse HDAC4 gene by homologous recom-
runted and markedly underrepresented (Figure 1D), andbination. The HDAC4 gene contains 31 exons encom-
passing approximately 425 kilobases of DNA on mouse no HDAC4-null mice survived to weaning. As discussed
Control of Skeletogenesis by HDAC4
557
Figure 2. Premature Ossification in HDAC4/ Mice
(A) Skeletons from wild-type and HDAC4/ mice at P8 were stained with Alizarin red and Alcian blue as described in Experimental Procedures.
Images show ribcages (a and b), the ventral chondrocranium (c and d), vertebrae (e and f), and the hyoid bone (g and h). Bones in (c) are
marked in the wild-type sample as follows: ps, presphenoid; bs, basisphenoid; bo, basioccipital; and eo, exoccipital. Arrowheads mark
synchondroses in the wild-type skull, which are completely ossified in the HDAC4 mutant. Arrowheads also mark regions of mineralized
chondrocostal cartilage in the HDAC4/ mice (b).
(B) Skeletons from E18 wild-type or HDAC4 mutant mice were stained with Alizarin red and Alcian blue as in (A). Aberrant ossification in the
wrist (b) and the vertebrae (d) is evident in the HDAC4/ skeletons as marked by the arrowheads.
below, the primary cause of growth retardation and and of nonmineralized cartilage with Alizarin red and
eventual death of HDAC4 mutant mice appears to be Alcian blue, respectively, revealed premature mineral-
the inappropriate ossification of cartilaginous skeletal ization of cartilage in skeletal elements ossifying through
elements, which impacts on mobility and ability to endochondral ossification in all mutant mice analyzed
breathe. at P8. This was particularly evident in the chondrocostal
To confirm that the targeted mutation eliminated func- cartilage (Figures 2Aa and 2Ab). In addition, the syn-
tional HDAC4, we performed RT-PCR using primers for chondroses in the base of the skull between the pre-
sequences upstream and downstream of the lacZ inser- sphenoid and basisphenoid bones and between the ba-
tion site. There was a complete absence of wild-type sisphenoid and basioccipital bones were completely
HDAC4 transcripts in tissues from homozygous mutant mineralized in HDAC4/ but not in wild-type mice (Fig-
mice (Figure 1E). We also examined the expression of ures 2Ac and 2Ad). This fusion prevents longitudinal
HDACs 1, 2, 3, 5, 6, 7, 8, and 9 by RT-PCR in tissues growth of the skull and results in dorsal and caudal
from wild-type and HDAC4 mutant mice. Transcripts displacement of the brain, producing a domed skull. In
encoding these HDACs were expressed at normal levels the vertebrae of HDAC4/mice, the ossification centers
in the mutant, indicating that other HDACs were not of the arch and body were fused such that no cartilage
upregulated to compensate for the absence of HDAC4. remained (Figures 2Ae and 2Af). The cartilaginous re-
gions of the hyoid bone were also completely ossified
in the HDAC4 mutant mice (Figures 2Ag and 2Ah). BonesHDAC4-Null Mice Display Skeletal Defects
that form through intramembranous ossification, i.e.,Tissue dissections and histological examination of
without a cartilaginous intermediate, such as bones ofHDAC4-null mice revealed no obvious abnormalities of
the cranium and the clavicle, were unaffected in thethe heart, skeletal muscle, or other major organs exam-
mutant mice. These phenotypic abnormalities were al-ined. However, numerous skeletal abnormalities were
readily apparent. Staining of mineralized bone/cartilage ready present at E18 of embryonic development. In-
Cell
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Figure 3. Ectopic Chondrocyte Hypertrophy in HDAC4/ Mice
(A) Premature chondrocyte hypertrophy in HDAC4/ mice. Hematoxylin and eosin staining was performed on sections of ribs isolated from
wild-type (a, c, and e) and HDAC4/ (b, d, and f) mice at P2, P5, and P8. Arrowheads in (a) and (b) mark sternum, which is abnormally ossified
in the HDAC4 mutant. Arrowheads in (c)–(f) mark the ribs in which chondrocytes are prematurely hypertrophied in the HDAC4 mutant.
(B) Higher magnification of ribs from wild-type (a, c, and e) and HDAC4/ (b, d, and f) mice. Arrowheads point to ectopic chondrocyte
hypertrophy at P2 and P5 (b and d) and ossification at P8 (f) in the HDAC4 mutant.
(C) Immunohistochemistry of HDAC4 and Runx2 was performed on E18.5 ribs. HDAC4 expression is localized to the prehypertrophic and
hypertrophic zones paralleling the staining pattern of Runx2. No HDAC4 staining is observed in the proliferating chondrocytes or trabeculated
bone. Phz, prehypertrophic zone; pz, proliferative zone.
(D) Western blot of whole-cell (C) and nuclear extracts (N) from primary chondrocytes and osteoblasts for Runx2 and HDAC4. Runx2 is
expressed in both cell types, whereas HDAC4 is expressed only in chondrocytes.
deed, examination of the developing wrist revealed pre- specific matrix. The specificity of the bone abnormalities
in HDAC4 mutant mice suggested that the primary de-mature mineralization in HDAC4/ animals (Figure 2B).
Fusion of the ossification centers of the arch and body fect might be in the control of chondrocyte hypertrophy .
of the vertebrae was also beginning at this stage.
Chondrocyte hypertrophy is a mandatory process Ectopic Chondrocyte Hypertrophy
in HDAC4-Null Miceduring endochondral bone formation. The cartilage
growth plate of developing bones consists of proliferat- Since the chondrocostal cartilage never mineralizes in
wild-type mice, whereas it was almost completely miner-ing chondrocytes that exit the cell cycle and transition
to become prehypertrophic and then hypertrophic chon- alized in HDAC4-null animals, we focused our attention
on this skeletal element. To pinpoint the onset of skeletaldrocytes (Karsenty and Wagner, 2002). Hypertrophic
chondrocytes then undergo apoptosis and are eventu- abnormalities in HDAC4-null mice, we examined the
chondrocostal cartilage at time points before (E18, P0,ally replaced by osteoblasts that lay down the bone-
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P2, and P5) and after (P8) extensive ectopic ossification
was observed. No abnormalities in the chondrocostal
cartilage were observed at E18 or P0 (data not shown).
By P2, hypertrophic chondrocytes were visible in the
chondrocostal cartilage of mutant mice but not in their
wild-type littermates (Figures 3A and 3B). At P5, hyper-
trophic chondrocytes were present throughout the
chondrocostal cartilage of the mutants, and by P8, a
mature ossification center was established and hyper-
trophic cartilage was replaced by trabeculated bone
(Figures 3A and 3B). These phenotypic abnormalities
were not restricted to the chondrocostal cartilage and
were also evident in other skeletal elements such as the
vertebrae, occipital sutures, and the sternum, which was
ossified already at P2 (data not shown and Figure 3A).
Premature chondrocyte hypertrophy in HDAC4-null
animals was also demonstrated molecularly. Indian
hedgehog (Ihh) secretion from prehypertrophic chon-
drocytes tightly controls chondrocyte hypertrophy and
differentiation (Vortkamp et al., 1996, Kronenberg, 2003).
Recently, the Ihh gene was shown to be a direct tran-
scriptional target gene of Runx2 (Yoshida et al., 2004).
At E18.5, a developmental stage when histological ab-
normalities were not yet noticeable, Ihh expression was
dramatically increased in the chondrocostal cartilage
of the mutant compared to WT littermates (Figure 4A).
Runx2 also regulates its own expression by binding its
own gene promoter, thereby fulfilling a positive autoreg-
ulatory loop (Ducy et al., 1999). Consistent with the pos-
sible enhancement of Runx2 activity in developing skel-
etal elements of HDAC4 mutant mice, Runx2 expression
was upregulated in the chondrocostal cartilage of the
mutant (Figure 4A). Following this increase in Ihh and
Runx2 expression, 1(X) collagen, a marker of hypertro-
phic chondrocytes, began to be expressed in chondro-
costal chondrocytes of HDAC4 mutants at P2 (Figure
4B). By P8, expression of the osteoblast marker, 1(I)
collagen, confirmed the invasion of osteoblasts and the
presence of bone trabeculae, following the presence of
an established growth plate in HDAC4/ chondrocostal
Figure 4. Increased Expression of Markers of Hypertrophic Chon-cartilage (Figure 4B).
drocytes and Bone in HDAC4/ Mice
The above results suggested that the skeletal abnor-
(A) Expression of Indian hedgehog (Ihh) and Runx2 (shown in red)malities in HDAC4 mutant mice arose from a primary
was detected by in situ hybridization of chondrocostal cartilage from
defect in the regulation of chondrocyte hypertrophy. To E18.5 and E16.5 specimens, respectively. Ihh and Runx2 expression
determine if HDAC4 was expressed in a pattern com- was upregulated precociously in the mutant.
(B) Expression of 1(I) collagen (shown in red) and 1(X) collagenpatible with such a phenotype, immunohistochemical
(shown in blue) was detected by in situ hybridization of ribs fromanalysis was performed. HDAC4 was not expressed at
wild-type (a, c, and e) and HDAC4/ (b, d, and f) mice at P2, P5,detectable levels in proliferating chondrocytes but was
and P8. Arrowheads in (a) and (b) mark chondrocostal cartilage,upregulated in prehypertrophic chondrocytes in the which is abnormally ossified in the HDAC4 mutant. Arrowheads in
growth plate at E18.5 (Figure 3C). Expression of HDAC4 (c)–(f) mark the ribs in which chondrocytes are prematurely hypertro-
diminished through the area of hypertrophic chondro- phied in the HDAC4 mutant. Extensive ossification can be seen in
the mutant by P8, whereas no evidence of ossification is detectedcytes. HDAC4 expression was not visible by immuno-
in these developing skeletal elements of the wild-type animal atstaining of the bone or osteoblasts. Expression of
this stage.HDACs 5, 7, and 9 was not detected in developing bones
(data not shown), suggesting that HDAC4 is the sole
class II HDAC involved in chondrocyte hypertrophy and HDAC4 Is a Runx2 Corepressor
skeletogenesis during embryogenesis. The phenotypic abnormalities noted in HDAC4/ mice
Western blot analysis of whole-cell and nuclear ex- are reminiscent of those observed in transgenic mice
tracts of isolated osteoblasts and chondrocytes also with prolonged expression of Runx2 in prehypertrophic
confirmed the specific expression of HDAC4 in chondro- cartilage (Takeda et al., 2001; Ueta et al., 2001). Given the
cytes (Figure 3D). In contrast, Runx2 was readily detect- expression of HDAC4 in prehypertrophic chondrocytes
able in both cell types as described previously (Ducy et and the abnormal chondrocyte differentiation seen in
HDAC4/ mice, we speculated that chondrocyte hyper-al., 1997; Takeda et al., 2001).
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Figure 5. Repression of Runx2 Activity by Association with HDAC4
(A) Left panel: COS cells were transfected with the p6OSE2-Luc reporter containing six copies of the Runx2 binding site with or without
expression plasmids encoding Runx2 (100 ng) and wild-type HDAC4 or signal-resistant HDAC4 mutant (HDAC4-S/A) in increasing amounts
(10, 25, 50, 100, or 200 ng). Right panel: COS cells were transfected with the pOG2-Luc reporter containing a portion of the osteocalcin
promoter with or without expression plasmids encoding Runx2 (100 ng) and wild-type HDAC4 or signal-resistant HDAC4 (100 ng). Transfections
were also performed with pOG2-Luc constructs containing mutations in the Runx2 binding sites, mOSE1-Luc and mOSE2-Luc. The data
represent the mean  the SEM.
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trophy might require the release of Runx2 from a repres- had no effect on Runx2 binding. We conclude that the
association of HDAC4 with the Runt domain of Runx2sive influence of HDAC4. To address this possibility, we
tested the effect of HDAC4 on the transcriptional activity interferes with DNA binding by Runx2 and, conse-
quently, inhibits activation of Runx2 target genes.of Runx2. Indeed, the ability of Runx2 to activate a lucif-
erase reporter controlled by tandem copies of the Runx2
binding site was repressed by HDAC4 in a dose-depen- Detection of HDAC4-Runx2 Interaction
dent manner (Figure 5A). A signal-resistant and constitu- by Chromatin Immunoprecipitation
tively nuclear mutant of HDAC4 in which three serines To further explore the potential role of HDAC4 in repres-
responsible for nuclear export were mutated to alanines sion of Runx2 activity, we examined the effect of HDAC4
(HDAC4-S/A) was an even more potent repressor of on Runx2 association with the Runx2 promoter by chro-
Runx2. HDAC4 repression was dependent on Runx2 matin immunoprecipitation (ChIP) of extracts from
DNA binding, as a reporter construct containing a mu- mouse primary chondrocytes infected with adenovirus
tant Runx2 site was largely unaffected by HDAC4 (Figure expression vectors encoding HDAC4 or GFP as a nega-
5A). In contrast to the complete inhibition of Runx2 activ- tive control. As shown in Figure 5E, the association of
ity by HDAC4, the activity of Sox9, a transcription factor Runx2 with the Runx2 promoter was readily detected
required for commitment to the chondrocyte lineage by ChIP assay, and this interaction was diminished in
(Akiyama et al., 2002), was only modestly repressed by the presence of HDAC4. Adenoviral expression of
HDAC4 (data not shown). These results suggest that HDAC4 also specifically suppressed the acetylation of
Runx2 is a key target for the repressive influence of histone H3 on the Runx2 promoter. These results sup-
HDAC4 on chondrocyte hypertrophy and mineralization port the conclusion that HDAC4 negatively influences
of developing bones. Runx2 activity in vivo and provide a potential explana-
tion for the increase in Runx2 expression in HDAC4
mutant mice.HDAC4 Interacts Directly with Runx2
To explore the mechanism for HDAC4-mediated repres-
sion of Runx2 activity, we tested whether HDAC4 and HDAC4 Is Sufficient to Inhibit Chondrocyte
Hypertrophy In VivoRunx2 could physically interact. As shown in Figure 5B,
coimmunoprecipitation experiments demonstrated the The above findings suggested that HDAC4 suppressed
Runx2 activity, which would be expected to preventassociation of HDAC4 and Runx2. This interaction was
localized to the Runt DNA binding domain of Runx2. chondrocyte hypertrophy and, therefore, bone forma-
tion in skeletal elements that ossify through endochon-The Runx2 interaction domain of HDAC4 was localized
to the first 220 amino acids of the protein, which also dral bone formation. To determine whether HDAC4
could inhibit chondrocyte hypertrophy in vivo, we gener-contains the MEF2 binding region. HDAC4 binding to
Runx2 was necessary for full repression of Runx2 activ- ated mice bearing a transgene in which the signal-resis-
tant HDAC4 mutant was overexpressed in proliferatingity (Figure 5C). However, we observed residual repres-
sive activity with two HDAC4 deletion mutants (301– chondrocytes under control of the 1(II) collagen pro-
moter. Skeletons of at least 12 1(II)-HDAC4 transgenic1084 and 641–1084) that did not display detectable
binding to Runx2 (Figure 5C). Whether the latter mutants animals were analyzed at E18.5. As shown in Figure
6A, 1(II)-HDAC4 transgenic mice displayed a severebind Runx2 weakly or act through a mechanism distinct
from that of the Runx2 binding domain of HDAC4 is un- skeletal phenotype, mimicking that of Runx2-deficient
mice, characterized by the lack of mineralized bone asclear.
The observation that HDAC4 interacts with the Runx2 detected by Alizarin red staining (Komori et al., 1997;
Otto et al., 1997). All bones ossifying through an endo-DNA binding domain suggested that it might also inhibit
Runx2 DNA binding activity. Indeed, as shown in Figure chondral process were affected. This was particularly
evident in the ribcage, in vertebrae, and at the base of5D, HDAC4 inhibited the ability of Runx2 to bind DNA
in vitro. In contrast, ATF4, another transcription factor the skull. In contrast, bones that form through intramem-
branous ossification, such as the clavicle, were unaf-important in osteoblast differentiation (Yang et al., 2004),
(B) Top panel: COS cells were transfected with expression plasmids encoding Flag-epitope-tagged Runx2 deletion mutants (shown to the
left) and HA-tagged HDAC4. Flag-Runx2 was immunoprecipitated with an anti-Flag antibody, followed by Western blot analysis to detect HA-
HDAC4 binding. Bottom panel: COS cells were transfected with expression plasmids encoding Flag-epitope-tagged HDAC4 deletion mutants
(shown to the left) and Runx2. Flag-HDAC4 was immunoprecipitated with an anti-Flag antibody, followed by Western blot analysis to detect
Runx2 binding.
(C) COS cells were transfected with the p6OSE2-Luc reporter and expression plasmids encoding Runx2 and the various HDAC4 deletion
mutants shown in (B). The data represent the mean  the SEM.
(D) Electromobility shift assays were performed with a labeled OSE2 probe and GST-Runx2. Increasing amounts of recombinant HDAC4 or
ATF4 translated in vitro were added to the DNA binding reaction, as indicated. As a control, equivalent amounts of unprogrammed lysate
were used. The upper arrowhead depicts the OSE2/Runx2 complex. Free unbound probe is indicated at the bottom of the gel.
(E) ChIP assays were performed using soluble chromatin prepared from mouse primary chondrocytes infected with adenovirus expression
constructs encoding HDAC4 or GFP, as indicated. Chromatin was immunoprecipitated with nonimmune rabbit IgG or antibodies specific for
Runx2 or acetylated histone H3, as indicated, and precipitated genomic DNA was analyzed by PCR using primers for the Runx2 promoter,
which contains a Runx2 binding site. An input control in which PCR amplification was performed prior to immunoprecipitation is also shown.
HDAC4 specifically perturbs the association of Runx2 with its target sequence in chromatin and suppresses acetylation of histone H3 on the
Runx2 promoter.
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Figure 6. HDAC4 Inhibits Chondrocyte Hypertrophy In Vivo
(A) Skeletal preparations from 1(II)-HDAC4 transgenic or wild-type embryos at E18.5 were stained with Alizarin red and Alcian blue to visualize
mineralized bone and cartilage, respectively. Skeletal elements shown are ribcage (a and b), forelimb (c and d), vertebrae (e and f), and the
base of the skull (g and h). Note that the clavicle (cl) is unaffected in the transgenic mouse (d). The abbreviations in the bottom panel are as
follows: ps, presphenoid; bs, basisphenoid; bo, basiocciptal; and eo, exoccipital. Arrowheads in (e) point to ossification centers and in (f) to
the corresponding region which lacks ossification.
(B) Histological analysis and in situ hybridization were performed on forearms isolated from 1(II)-HDAC4 transgenic or wild-type control
embryos at E18.5. The dashed lines depict the boundaries between the proliferating/prehypertrophic chondrocytes, hypertrophic chondrocytes,
and bone. The structures in the top right panel are noted as the humerus (h) and radius (r).
fected by forced expression of HDAC4 (Figure 6A). The pressed in the cartilaginous skeletal elements of trans-
genic animals, consistent with the lack of chondrocytespecificity of this phenotype provides strong support
for the involvement of HDAC4 in the control of endo- hypertrophy. There was also a complete absence of
expression of 1(I) collagen, a marker of trabeculatedchondral bone formation.
Certain transgenic animals also displayed severe fore- bone, in skeletal elements of transgenic mice.
shortening of the limbs. An example of this is shown in
Figure 6Ad in which the growth of the forelimb is mark- Discussion
edly blunted. Histological analysis of 1(II)-HDAC4
transgenic mice revealed a complete lack of hypertro- Most bones ossify through endochondral ossification,
which includes an intermediary step in which a cartilagi-phic chondrocytes and osteoblasts and an absence of
bone trabeculae (Figure 6B). nous template containing hypertrophic chondrocytes
prefigures the future bone. The results presented hereWe further defined the molecular defects associated
with ectopic HDAC4 expression by analyzing the ex- demonstrate that HDAC4 governs chondrocyte hyper-
trophy and thereby endochondral bone formation bypression of collagen genes specific for the different
phases of chondrocyte development. 1(II) collagen, a negatively regulating the activity of Runx2. The following
observations support this conclusion. (1) HDAC4 is ex-marker of proliferating chondrocytes, was expressed
throughout the cartilaginous skeletal elements of the pressed in prehypertrophic chondrocytes in vivo. (2)
HDAC4 mutant mice display precocious and ectopictransgenic forelimb at E18.5 (Figure 6B). 1(X) collagen,
a marker of hypertrophic chondrocytes, was not ex- mineralization of endochondral bones, mimicking the
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Figure 7. A Model for the Control of Chon-
drocyte Hypertrophy and Bone Development
by HDAC4
A schematic of cellular transitions involved in
endochondral bone development is shown at
the top. The regulatory step controlled by
HDAC4 is shown at the bottom.
Runx2 gain-of-function phenotype. (3) Expression of a ing HDACs 5 and 9 and have not observed any exacerba-
tion of the HDAC4 skeletal phenotype, further indicatingsignal-resistant HDAC4 mutant in prehypertrophic chon-
drocytes prevents hypertrophy and ossification and phe- the lack of functional overlap of these class II HDACs
with HDAC4 (unpublished data).nocopies the Runx2 loss-of-function phenotype. (4)
HDAC4 physically associates with Runx2 with conse-
quent repression of Runx2 DNA binding and transcrip- Repression of Runx2 Activity by HDAC4
tional activity. Taken together, these results establish Runx2 is a member of the runt family of transcription
HDAC4 as a key regulator of chondrocyte differentiation factors originally isolated on the basis of its ability to
and endochondral bone formation. activate transcription of the osteoblast-specific osteo-
calcin gene (Ducy et al., 1997). Runx2 is necessary for
osteoblast differentiation in vivo (Komori et al., 1997;Regulation of Chondrocyte
Hypertrophy by HDAC4 Otto et al., 1997) and is a critical mediator of chondrocyte
hypertrophy (Inada et al., 1999; Kim et al., 1999; TakedaEndochondral bone formation begins with the conden-
sation of mesenchymal cells and their subsequent differ- et al., 2001). Runx2 is expressed in prehypertrophic and
hypertrophic chondrocytes during skeletogenesis. Sev-entiation into chondrocytes, which organize into a tem-
plate of the eventual bone comprised of a succession of eral lines of evidence indicate that Runx2 is a physiologi-
cal regulator of chondrocyte hypertrophy. (1) Hypertro-proliferating, prehypertrophic, and hypertrophic zones
(Erlebacher et al., 1995). The extracellular matrix sur- phic chondrocytes are absent in multiple skeletal
elements in Runx2-null mice (Inada et al., 1999; Kimrounding hypertrophic chondrocytes is permissive to
vascular invasion, which allows the ingression of the et al., 1999). (2) Constitutive expression of Runx2 in
prehypertrophic chondrocytes leads to premature andskeletal cells of the osteoblast lineage (Figure 7).
Our results suggest that the primary defect in the ectopic chondrocyte hypertrophy in a manner strikingly
similar to what we observed in HDAC4-null mice (TakedaHDAC4/ mice occurs in the control of chondrocyte
hypertrophy. The formation of cartilaginous templates of et al., 2001; Ueta et al., 2001). (3) Expression of a domi-
nant-negative Runx2 mutant inhibits chondrocyte hy-endochondral bones occurs normally in HDAC4 mutant
mice. However, the onset of chondrocyte hypertrophy pertrophy and ossification in vivo (Ueta et al., 2001).
The precise timing of chondrocyte hypertrophy duringis accelerated and, consequently, endochondral miner-
alization occurs precociously. These findings suggest skeletogenesis suggests that Runx2 function must be
regulated during this process so that bone formationthat a primary function of HDAC4 is to delay chondrocyte
hypertrophy and thereby to determine the timing and does not occur prematurely. Our results identify HDAC4
as such a regulator. While we cannot rule out the possi-extent of ossification of endochondral bones.
The role of HDAC4 as a repressor of chondrocyte ble involvement of transcription factors in addition to
Runx2 as targets for repression by HDAC4 in the devel-hypertrophy appears to be unique and distinct from the
functions of other class II HDACs based on the lack of oping skeleton, the remarkable resemblance of the
HDAC4 mutant and Runx2 gain-of-function phenotypesexpression of HDACs 5, 7, or 9 in developing bones. In
addition, knockout mice lacking these class II HDACs and of the Runx2 mutant and HDAC4 gain-of-function
phenotypes in vivo, coupled with the direct interactionshow distinct phenotypes. Mice lacking HDACs 5 or 9
are viable and show no skeletal abnormalities (Zhang of these proteins, argues strongly for the central role of
the Runx2-HDAC4 interaction in the control of chondro-et al., 2002, Chang et al., 2004), and mice lacking HDAC7
die during mid-gestation from cardiovascular defects cyte development.
The expression pattern of Runx2 in prehypertrophic(S. Chang and E.N.O., unpublished data). We have also
generated mice in which the HDAC4-null mutation has chondrocytes (Takeda et al., 2001) overlaps with that of
HDAC4. Based on the similarity between HDAC4 loss-been combined with null mutations in the genes encod-
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of-function and Runx2 gain-of-function phenotypes, cient mice display severe skeletal abnormalities charac-
terized by a marked decrease in chondrocyte prolifera-both of which show premature chondrocyte hypertrophy
and aberrant endochondral ossification, we tested tion and osteoblast differentiation (St-Jacques et al.,
1999). Ihh secretion by prehypertrophic chondrocyteswhether HDAC4 might inhibit Runx2 activity. HDAC4
physically associated with Runx2 and inhibited its ability positively regulates chondrocyte proliferation and in-
duces expression of parathyroid hormone-related pep-to transactivate target promoters. Likewise, chondro-
cyte overexpression of HDAC4 produced a similar phe- tide (PTHrP) in the articular perichondrium, which inhib-
its differentiation of prehypertrophic to hypertrophicnotype to the dominant-negative Runx2, i.e., inhibition of
chondrocyte hypertrophy and subsequent ossification. chondrocytes (Vortkamp et al., 1996). Cells no longer
expressing Ihh, and released from the inhibitory effectsThese results suggest that HDAC4 tightly controls
Runx2 activity during chondrocyte differentiation, possi- of PTHrP, become hypertrophic. In addition, Ihh may
promote hypertrophic chondrocyte maturation after thebly until certain signals release Runx2 from the repres-
sive influence of HDAC4. In HDAC4 mutant mice, Runx2 cells are outside the inhibitory range of PTHrP (Akiyama
et al., 1999; Stott and Chuong, 1997). The Ihh gene is aexpression is elevated in regions of developing skeletal
elements that display precocious chondrocyte hypertro- direct target gene of Runx2 (Yoshida et al., 2004), and
Runx2 expression in proliferating chondrocytes inducesphy, suggesting that the Runx2 gene is itself a target for
repression by HDAC4. Consistent with this conclusion, Ihh expression in prehypertrophic chondrocytes (Takeda
et al., 2001). A similar induction of Ihh expression isRunx2 has been shown to bind and activate its own
promoter via a positive feedback loop (Ducy et al., 1999). seen in prehypertrophic chondrocytes appearing in the
chondrocostal cartilage of HDAC4/ mice (Figure 4A)We show here by ChIP assays that HDAC4 associates
with the Runx2 promoter and reduces histone acetyla- before any histologic changes are evident. These data
suggest a model in which HDAC4 repression of Runx2tion and Runx2 binding to the promoter.
Our results indicate that association of HDAC4 with activity controls proper temporal and spatial Ihh expres-
sion. Therefore, in the HDAC4/ mice, ectopic chondro-the Runt domain of Runx2 inhibits Runx2 DNA binding.
These findings suggest that the inhibitory influence of cyte maturation leads to increased Ihh expression with
subsequent chondrocyte hypertrophy. Aberrant Ihh ex-HDAC4 on Runx2 occurs independently of HDAC cata-
lytic activity. It is notable in this regard that other class pression also activates osteoblast differentiation in the
perichondrium leading to subsequent osteoblast inva-II HDACs have been shown to repress transcription in
the absence of a functional catalytic domain (Zhang et sion and bone trabeculation (St-Jacques et al., 1999).
al., 2001). It is curious that two HDAC4 mutant proteins
lacking the Runx2 binding domain retained residual re- Control of Cellular Hypertrophy by Class II HDACs
pressive activity toward Runx2. We are uncertain of the The bone phenotype of HDAC4 knockout mice bears
mechanism of action of these mutants, but their partial an intriguing resemblance to the cardiac phenotype of
repressive activity suggests that HDAC4 may have tran- HDAC9 mutant mice, suggesting common mechanisms
scriptional targets in addition to Runx2 in the pathway of action of these HDACs. Mice lacking HDAC9 display
for chondrocyte differentiation. a heightened sensitivity to signals that promote cardiac
We have previously demonstrated that class II HDACs hypertrophy, reflecting the enhanced activation of the
act as signal-responsive repressors of cardiac hypertro- MEF2 transcription factor. HDAC5 knockout mice dis-
phy (Zhang et al., 2002; Chang et al., 2004). The activity play the same phenotype as HDAC9 mutants, and
of class II HDACs is influenced by phosphorylation of HDAC5/9 double mutants show an even greater degree
specific serine residues, which stimulates their nuclear of cardiac hypertrophy (Chang et al., 2004). Thus, we
export and derepression of their target genes (Chang propose that class II HDACs may act within diverse
et al., 2004; McKinsey et al., 2000a, 2000b). We observed cell types to control hypertrophic growth in response
nuclear staining of HDAC4 in both prehypertrophic and, to developmental or pathological signals. Hypertrophic
to a lesser extent, hypertrophic chondrocytes. No evi- growth of different cell types depends on different stim-
dence was seen of cytoplasmic-localized HDAC4 in the uli and is controlled by distinct sets of transcription
chondrocytes of the growth plate. Thus, it appears that factors—MEF2 in the case of cardiomyocytes and
loss of HDAC4 expression triggers activation of Runx2 Runx2 in the case of chondrocytes. The realization that
and chondrocyte maturation. cellular hypertrophy is governed by class II HDACs
Recently, the Twist-1 and -2 transcription factors were through their association with specific target transcrip-
shown to repress Runx2 activity (Bialek et al., 2004). tion factors suggests possible strategies for therapeuti-
However, the mechanism involved in this form of repres- cally manipulating this mechanism in the settings of
sion is distinct from that of HDAC4 in one important development and disease.
respect. Twist expression is restricted to osteoblasts,
whereas the phenotype of the HDAC4 mutant mouse
Experimental Procedures
reflects a primary defect in chondrocyte maturation and
differentiation. Thus, Twist and HDAC4 act in entirely Generation of HDAC4-Null Mice
The HDAC4 targeting vector was created by cloning a 4-kb genomicdifferent steps of the skeletogenic process to regulate
fragment between exons 5 and 6 and a 1.3-kb fragment betweenRunx2 function.
exons 6 and 7 into the pN-Z-TK2 vector (kindly provided by R. Pal-
miter). This vector encodes a nuclear LacZ and contains a neomycin
Regulation of Ihh Expression by HDAC4 resistance cassette. The HDAC4 targeting vector was linearized and
Longitudinal bone growth is driven primarily by the rate electroporated into ES cells. Resulting clones were screened for
correct homologous recombination by Southern blot analysis. ESof production of hypertrophic chondrocytes. Ihh-defi-
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clones with a targeted disruption of the HDAC4 locus were injected manufacturer’s instructions. For electromobility shift assay (EMSA),
double-stranded oligonucleotides corresponding to the osteocalcininto C57BL/6 blastocysts to produce chimeric mice. Chimeric mice
obtained from one targeted ES clone were bred to C57BL/6 mice OSE2 site containing the Runx2 binding site were 32P-labeled. EMSA
was performed as previously described (Ducy et al., 1997).to obtain germline transmission. All experiments described here
were performed with mice of a C57BL/6/129 mixed background.
ChIP Assays
ChIP assays were performed using soluble chromatin prepared fromRNA Isolation and Analysis
primary mouse chondrocytes infected with adenovirus expressionTotal RNA was isolated from tissues with Trizol reagent and used
vectors encoding HDAC4 or GFP at a multiplicity of infection of 10.as a template for reverse transcriptase with primers specific for
Primer sequences are available upon request.each HDAC transcript (Invitrogen) according to manufacturer’s in-
structions. Primer sequences are available upon request.
Transgenic Mice
A chondrocyte-specific HDAC4 transgene was constructed by sub-Cartilage and Bone Staining
cloning the signal-resistant HDAC4-S/A mutant, in which serinesEmbryonic or newborn mice were skinned, eviscerated, and fixed
246, 467, and 632 were changed to alanines (McKinsey et al., 2000b),in ethanol. Skeletal preparations were stained using Alcian blue and
between a 3-kb fragment of the1(II) promoter and its 3-kb chondro-Alizarin red, respectively, as described previously (McLeod, 1980).
cyte-specific enhancer region (Zhou et al., 1998). Linearized trans-Soft tissue was removed by incubation in 2% KOH.
genic construct was injected into the pronuclei of fertilized oocytes
as described previously (Cheng et al., 1993). At least 12 F0 transgenicHistological Analysis
offspring were harvested and analyzed for changes in skeletal devel-Tissues were fixed in 10% phosphate-buffered formalin at 4C. Sam-
opment. The severity of the skeletal phenotype in these mice corre-ples were then embedded in paraffin, sectioned at 5m, and stained
lated with transgene copy number.with hematoxylin and eosin.
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